Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8045)
All Articles published online
|
Publishing Process of This Article
|
Feb 10, 2016 (publication date) through Jun 1, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kilari D, Guancial E, Kim ES. Role of copper transporters in platinum resistance. World J Clin Oncol 2016; 7(1): 106-113 [PMID: 26862494 DOI: 10.5306/wjco.v7.i1.106] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v7/i1/106.htm |
| Number | Citing Articles |
| 1 |
Rui Liu, Yanxia Gao, Nannan Liu, Yuping Suo. Nanoparticles loading porphyrin sensitizers in improvement of photodynamic therapy for ovarian cancer. Photodiagnosis and Photodynamic Therapy 2021; 33: 102156 doi: 10.1016/j.pdpdt.2020.102156
|
| 2 |
Emilia Kozłowska, Tuulia Vallius, Johanna Hynninen, Sakari Hietanen, Anniina Färkkilä, Sampsa Hautaniemi. Virtual clinical trials identify effective combination therapies in ovarian cancer. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-55068-z
|
| 3 |
Parisa Maleki Dana, Fatemeh Sadoughi, Zatollah Asemi, Bahman Yousefi. The role of polyphenols in overcoming cancer drug resistance: a comprehensive review. Cellular & Molecular Biology Letters 2022; 27(1) doi: 10.1186/s11658-021-00301-9
|
| 4 |
Cut Adeya Adella, M. Fidel Ganis Siregar, Imam Budi Putra, Poppy Anjelisa Hasibuan, Andrijono Andrijono, Adang Bachtiar, Sarma N. Lumbanraja, Iqbal Pahlevi Nasution. The Effect of Melatonin and Cisplatin Combination Using Copper-Transporting ATPase-1, P-Glycoprotein, and Gamma-Glutamylcysteinylglycine on Ovarian Cancer Biological Cell SKOV3. Open Access Macedonian Journal of Medical Sciences 2022; 10(B): 1079 doi: 10.3889/oamjms.2022.8885
|
| 5 |
Ahmad Nasimian, Mehreen Ahmed, Ingrid Hedenfalk, Julhash U. Kazi. A deep tabular data learning model predicting cisplatin sensitivity identifies BCL2L1 dependency in cancer. Computational and Structural Biotechnology Journal 2023; 21: 956 doi: 10.1016/j.csbj.2023.01.020
|
| 6 |
Paul Rocchi, Delphine Brichart-Vernos, François Lux, Isabelle Morfin, Laurent David, Claire Rodriguez-Lafrasse, Olivier Tillement. A New Generation of Ultrasmall Nanoparticles Inducing Sensitization to Irradiation and Copper Depletion to Overcome Radioresistant and Invasive Cancers. Pharmaceutics 2022; 14(4): 814 doi: 10.3390/pharmaceutics14040814
|
| 7 |
Gabriel Braun, Martin Schaier, Paulina Werner, Sarah Theiner, Jürgen Zanghellini, Lukas Wisgrill, Nanna Fyhrquist, Gunda Koellensperger. MeXpose─A Modular Imaging Pipeline for the Quantitative Assessment of Cellular Metal Bioaccumulation. JACS Au 2024; doi: 10.1021/jacsau.4c00154
|
| 8 |
Jia Yee Lee, Richie R. Bhandare, Sai H.S. Boddu, Afzal B. Shaik, Lakshmana Prabu Saktivel, Gaurav Gupta, Poonam Negi, Muna Barakat, Sachin Kumar Singh, Kamal Dua, Dinesh Kumar Chellappan. Molecular mechanisms underlying the regulation of tumour suppressor genes in lung cancer. Biomedicine & Pharmacotherapy 2024; 173: 116275 doi: 10.1016/j.biopha.2024.116275
|
| 9 |
Arkene Levy, Carolina Leynes, Mirza Baig, Sue Anne Chew. The Application of Biomaterials in the Treatment of Platinum‐Resistant Ovarian Cancer. ChemMedChem 2019; 14(21): 1810 doi: 10.1002/cmdc.201900450
|
| 10 |
Maria Cetraz, Vasily Sen, Sarah Schoch, Karolin Streule, Valery Golubev, Andrea Hartwig, Beate Köberle. Platinum(IV)-nitroxyl complexes as possible candidates to circumvent cisplatin resistance in RT112 bladder cancer cells. Archives of Toxicology 2017; 91(2): 785 doi: 10.1007/s00204-016-1754-3
|
| 11 |
Aochang Chen, Pan Jiang, Falak Zeb, Xiaoyue Wu, Chuyue Xu, Lijun Chen, Qing Feng. EGCG regulates CTR1 expression through its pro‐oxidative property in non‐small‐cell lung cancer cells. Journal of Cellular Physiology 2020; 235(11): 7970 doi: 10.1002/jcp.29451
|
| 12 |
Miao Li, Rong Chen, Baoyan Ji, Chunmei Fan, Guanying Wang, Chenli Yue, Guoquan Li. Contribution of XPD and XPF Polymorphisms to Susceptibility of Non-Small Cell Lung Cancer in High-Altitude Areas. Public Health Genomics 2021; 24(3-4): 189 doi: 10.1159/000512641
|
| 13 |
Michela Chiappa, Federica Guffanti, Chiara Grasselli, Nicolò Panini, Alessandro Corbelli, Fabio Fiordaliso, Giovanna Damia. Different Patterns of Platinum Resistance in Ovarian Cancer Cells with Homologous Recombination Proficient and Deficient Background. International Journal of Molecular Sciences 2024; 25(5): 3049 doi: 10.3390/ijms25053049
|
| 14 |
Leyla Norouzi‐Barough, Mohammad Reza Sarookhani, Mohammadreza Sharifi, Sahar Moghbelinejad, Saranaz Jangjoo, Rasoul Salehi. Molecular mechanisms of drug resistance in ovarian cancer. Journal of Cellular Physiology 2018; 233(6): 4546 doi: 10.1002/jcp.26289
|
| 15 |
Krystal English, Andrew Shepherd, Ndidi-Ese Uzor, Ronnie Trinh, Annemieke Kavelaars, Cobi J. Heijnen. Astrocytes rescue neuronal health after cisplatin treatment through mitochondrial transfer. Acta Neuropathologica Communications 2020; 8(1) doi: 10.1186/s40478-020-00897-7
|
| 16 |
Most. Umme Bushra, Sanzana Fareen Rivu, Ali Ehsan Sifat, Noor Ahmed Nahid, Maizbha Uddin Ahmed, Mir Md. Abdullah Al-Mamun, Mohd Nazmul Hasan Apu, Md. Siddiqul Islam, Md. Reazul Islam, Mohammad Safiqul Islam, Abul Hasnat. Genetic polymorphisms of GSTP1, XRCC1, XPC and ERCC1: prediction of clinical outcome of platinum-based chemotherapy in advanced non-small cell lung cancer patients of Bangladesh. Molecular Biology Reports 2020; 47(9): 7073 doi: 10.1007/s11033-020-05771-2
|
| 17 |
Maja Cemazar, Gregor Sersa. Recent Advances in Electrochemotherapy. Bioelectricity 2019; 1(4): 204 doi: 10.1089/bioe.2019.0028
|
| 18 |
Xi Yang, Yingjie Yu, Xing Huang, Qixian Chen, Hui Wu, Ran Wang, Ruogu Qi, Yifeng Miao, Yongming Qiu. Delivery of platinum (II) drugs with bulky ligands in trans-geometry for overcoming cisplatin drug resistance. Materials Science and Engineering: C 2019; 96: 96 doi: 10.1016/j.msec.2018.10.092
|
| 19 |
Tiziano Marzo, Diego La Mendola. Looking Beyond DNA as the Target of Inorganic Chemotherapy Agents: The Key Role of Protein Metalation and Metal Homeostasis. Current Topics in Medicinal Chemistry 2021; 21(1): 3 doi: 10.2174/156802662101201211094545
|
| 20 |
Kazuma Fujita, Satoru Motoyama, Yusuke Sato, Akiyuki Wakita, Yushi Nagaki, Yoshihiro Minamiya, Masatomo Miura. Effects of SLC31A1 and ATP7B polymorphisms on platinum resistance in patients with esophageal squamous cell carcinoma receiving neoadjuvant chemoradiotherapy. Medical Oncology 2021; 38(1) doi: 10.1007/s12032-020-01450-1
|
| 21 |
Iftekhar Hassan, Azmat Ali Khan, Shazia Aman, Wajhul Qamar, Hossam Ebaid, Jameel Al-Tamimi, Ibrahim M. Alhazza, Ahmed M. Rady. Restrained management of copper level enhances the antineoplastic activity of imatinib in vitro and in vivo. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-19410-1
|
| 22 |
Prasath Manogaran, Narasimha Murthy Beeraka, Chih-Yang Huang, Viswanadha Vijaya Padma. Neferine and isoliensinine enhance ‘intracellular uptake of cisplatin’ and induce ‘ROS-mediated apoptosis’ in colorectal cancer cells – A comparative study. Food and Chemical Toxicology 2019; 132: 110652 doi: 10.1016/j.fct.2019.110652
|
| 23 |
Sarah Blagden, Mai Abdel Mouti, James Chettle. Ancient and modern: hints of a core post‐transcriptional network driving chemotherapy resistance in ovarian cancer. WIREs RNA 2018; 9(1) doi: 10.1002/wrna.1432
|
| 24 |
M. Michael Dcona, Koushambi Mitra, Matthew C. T. Hartman. Photocontrolled activation of small molecule cancer therapeutics. RSC Medicinal Chemistry 2020; 11(9): 982 doi: 10.1039/D0MD00107D
|
| 25 |
Kazuma Fujita, Satoru Motoyama, Yusuke Sato, Akiyuki Wakita, Yushi Nagaki, Yoshihiro Minamiya, Masatomo Miura. Association between ABCC2 polymorphism and hematological toxicity in patients with esophageal cancer receiving platinum plus 5-fluorouracil therapy. Esophagus 2022; 19(1): 146 doi: 10.1007/s10388-021-00865-7
|
| 26 |
Elena Puris, Gert Fricker, Mikko Gynther. The Role of Solute Carrier Transporters in Efficient Anticancer Drug Delivery and Therapy. Pharmaceutics 2023; 15(2): 364 doi: 10.3390/pharmaceutics15020364
|
| 27 |
Ashwin Chandra, Cima Pius, Madiha Nabeel, Maya Nair, Jamboor K. Vishwanatha, Sarfraz Ahmad, Riyaz Basha. Ovarian cancer: Current status and strategies for improving therapeutic outcomes. Cancer Medicine 2019; 8(16): 7018 doi: 10.1002/cam4.2560
|
| 28 |
Andrew C. Poon, Jordon M. Inkol, Anita K. Luu, Anthony J. Mutsaers. Effects of the potassium‐sparing diuretic amiloride on chemotherapy response in canine osteosarcoma cells. Journal of Veterinary Internal Medicine 2019; 33(2): 800 doi: 10.1111/jvim.15382
|
| 29 |
Yupeng Wang, Zhijian Luo, Dongfang Zhou, Xuefeng Wang, Jianjun Chen, Shipeng Gong, Zhiqiang Yu. Nano-assembly of ursolic acid with platinum prodrug overcomes multiple deactivation pathways in platinum-resistant ovarian cancer. Biomaterials Science 2021; 9(11): 4110 doi: 10.1039/D1BM00087J
|
| 30 |
Han Qiao, Zhichao Chen, Shuwen Fu, Xiang Yu, Mengchi Sun, Yinglei Zhai, Jin Sun. Emerging platinum(0) nanotherapeutics for efficient cancer therapy. Journal of Controlled Release 2022; 352: 276 doi: 10.1016/j.jconrel.2022.10.021
|
| 31 |
Rositsa Mihaylova, Anife Ahmedova, Denitsa Momekova, Georgi Momekov, Nikolay Danchev. Delineation of proapoptotic signaling of anthracene-shelled M2L4 metallacapsules and their synergistic activity with curcumin in cisplatin-sensitive and resistant tumor cell lines. Investigational New Drugs 2019; 37(6): 1117 doi: 10.1007/s10637-019-00738-y
|
| 32 |
Li-Ming Tan, Cheng-Feng Qiu, Tao Zhu, Yuan-Xiang Jin, Xi Li, Ji-Ye Yin, Wei Zhang, Hong-Hao Zhou, Zhao-Qian Liu. Genetic Polymorphisms and Platinum-based Chemotherapy Treatment Outcomes in Patients with Non-Small Cell Lung Cancer: A Genetic Epidemiology Study Based Meta-analysis. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-05642-0
|
| 33 |
Sae Hamaya, Kyoko Oura, Asahiro Morishita, Tsutomu Masaki. Cisplatin in Liver Cancer Therapy. International Journal of Molecular Sciences 2023; 24(13): 10858 doi: 10.3390/ijms241310858
|
| 34 |
Jeena John, Manas Kinra, Jayesh Mudgal, G. L. Viswanatha, K. Nandakumar. Animal models of chemotherapy-induced cognitive decline in preclinical drug development. Psychopharmacology 2021; 238(11): 3025 doi: 10.1007/s00213-021-05977-7
|
| 35 |
Reem Ali, Mustapha Aouida, Abdallah Alhaj Sulaiman, Srinivasan Madhusudan, Dindial Ramotar. Can Cisplatin Therapy Be Improved? Pathways That Can Be Targeted. International Journal of Molecular Sciences 2022; 23(13): 7241 doi: 10.3390/ijms23137241
|
| 36 |
Fabio Arnesano, Maria I. Nardella, Giovanni Natile. Platinum drugs, copper transporters and copper chelators. Coordination Chemistry Reviews 2018; 374: 254 doi: 10.1016/j.ccr.2018.07.003
|
| 37 |
Cristine L. Chisholm, Haitao Wang, Ada Hang-Heng Wong, Guelaguetza Vazquez-Ortiz, Weiping Chen, Xiaoling Xu, Chu-Xia Deng. Ammonium tetrathiomolybdate treatment targets the copper transporter ATP7A and enhances sensitivity of breast cancer to cisplatin. Oncotarget 2016; 7(51): 84439 doi: 10.18632/oncotarget.12992
|
| 38 |
Grazielle Paz, Gisele De Amorim, Janaina Fernandes. Metformin restores cisplatin cytotoxicity reduced by allantoin in CML in vitro. World Academy of Sciences Journal 2021; 3(5) doi: 10.3892/wasj.2021.116
|
| 39 |
Kenneth K. W. To, Ka M. Cheung, William C. S. Cho. Repurposing of triamterene as a histone deacetylase inhibitor to overcome cisplatin resistance in lung cancer treatment. Journal of Cancer Research and Clinical Oncology 2023; 149(10): 7217 doi: 10.1007/s00432-023-04641-1
|
| 40 |
Yuhui Yun, Yun Wang, Ende Yang, Xin Jing. Cuproptosis-Related Gene – SLC31A1, FDX1 and ATP7B – Polymorphisms are Associated with Risk of Lung Cancer. Pharmacogenomics and Personalized Medicine 2022; : 733 doi: 10.2147/PGPM.S372824
|
| 41 |
Meenu Maan, Moosa Abuzayeda, Eleftherios G. Kaklamanos, Mohamed Jamal, Mainak Dutta, Keyvan Moharamzadeh. Molecular insights into the role of electronic cigarettes in oral carcinogenesis. Critical Reviews in Toxicology 2023; 53(1): 1 doi: 10.1080/10408444.2023.2190764
|
| 42 |
Kirill Kiselyov. Channeling hope for uranium-induced kidney damage and beyond with TRPML1. Cell Calcium 2023; 115: 102799 doi: 10.1016/j.ceca.2023.102799
|
| 43 |
Shireen Chikara, Lokesh Dalasanur Nagaprashantha, Jyotsana Singhal, David Horne, Sanjay Awasthi, Sharad S. Singhal. Oxidative stress and dietary phytochemicals: Role in cancer chemoprevention and treatment. Cancer Letters 2018; 413: 122 doi: 10.1016/j.canlet.2017.11.002
|
| 44 |
Linrong Li, Lin Li, Qiang Sun. High expression of cuproptosis-related SLC31A1 gene in relation to unfavorable outcome and deregulated immune cell infiltration in breast cancer: an analysis based on public databases. BMC Bioinformatics 2022; 23(1) doi: 10.1186/s12859-022-04894-6
|
| 45 |
Jimmy Manyanga, Vengatesh Ganapathy, Célia Bouharati, Toral Mehta, Balaji Sadhasivam, Pawan Acharya, Daniel Zhao, Lurdes Queimado. Electronic cigarette aerosols alter the expression of cisplatin transporters and increase drug resistance in oral cancer cells. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-81148-0
|
| 46 |
Gloria Angelina Herrera-Quiterio, Sergio Encarnación-Guevara. The transmembrane proteins (TMEM) and their role in cell proliferation, migration, invasion, and epithelial-mesenchymal transition in cancer. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1244740
|
| 47 |
Dawid Przystupski, Olga Michel, Joanna Rossowska, Stanisław Kwiatkowski, Jolanta Saczko, Julita Kulbacka. The modulatory effect of green tea catechin on drug resistance in human ovarian cancer cells. Medicinal Chemistry Research 2019; 28(5): 657 doi: 10.1007/s00044-019-02324-6
|
| 48 |
Pengpeng Zhang, Bohan Li, Qianfeng Chen, Hui Wang, Qing Feng. Glucose restriction induces ROS-AMPK-mediated CTR1 expression and increases cisplatin efficiency in NSCLC. Cancer Letters 2022; 543: 215793 doi: 10.1016/j.canlet.2022.215793
|
| 49 |
Nadine S. Sommerfeld, Jana Gülzow, Alexander Roller, Klaudia Cseh, Michael A. Jakupec, Andreas Grohmann, Mathea Sophia Galanski, Bernhard K. Keppler. Antiproliferative Copper(II) and Platinum(II) Complexes with Bidentate N,N‐Donor Ligands. European Journal of Inorganic Chemistry 2017; 2017(24): 3115 doi: 10.1002/ejic.201700416
|
| 50 |
Avani Vyas, Roberto Gomez-Casal, Silvia Cruz-Rangel, Hugo Villanueva, Andrew G. Sikora, Pavithra Rajagopalan, Devraj Basu, Jonathan Pacheco, Gerald R. V. Hammond, Kirill Kiselyov, Umamaheswar Duvvuri. Lysosomal inhibition sensitizes TMEM16A-expressing cancer cells to chemotherapy. Proceedings of the National Academy of Sciences 2022; 119(12) doi: 10.1073/pnas.2100670119
|
| 51 |
Benjamin N. Forgie, Rewati Prakash, Carlos M. Telleria. Revisiting the Anti-Cancer Toxicity of Clinically Approved Platinating Derivatives. International Journal of Molecular Sciences 2022; 23(23): 15410 doi: 10.3390/ijms232315410
|
| 52 |
Asad Ali, Juber Akhtar, Usama Ahmad, Abdul Samad Basheer, Neha Jaiswal, Afroz Jahan.
Armamentarium in Drug Delivery for Colorectal Cancer
. Critical Reviews™ in Therapeutic Drug Carrier Systems 2023; 40(1): 1 doi: 10.1615/CritRevTherDrugCarrierSyst.2022039241
|
| 53 |
Janaina Fernandes, Gisele Cardoso de Amorim, Tallita Eduarda da Veiga, Jesiel Cardoso, Alberto Cardoso Arruda, Mara Silvia Pinheiro Arruda, Morgana T. L. Castelo-Branco. Allantoin reduces cell death induced by cisplatin: possible implications for tumor lysis syndrome management. JBIC Journal of Biological Inorganic Chemistry 2019; 24(4): 547 doi: 10.1007/s00775-019-01661-6
|
| 54 |
Ramon Handerson Gomes Teles, Angelica Ellen Graminha, Cosette M. Rivera-Cruz, Douglas Hideki Nakahata, André Luiz Barboza Formiga, Pedro Paulo Corbi, Marxa Leão Figueiredo, Márcia Regina Cominetti. Copper transporter 1 affinity as a delivery strategy to improve the cytotoxic profile of rationally designed copper(II) complexes for cancer treatment. Toxicology in Vitro 2020; 67: 104922 doi: 10.1016/j.tiv.2020.104922
|
| 55 |
Rashin Ghaffari, John H. Richburg. Mice with a Sertoli cell-specific knockout of the Ctr1 gene exhibit a reduced sensitivity to cisplatin-induced testicular germ cell apoptosis. Toxicology Research 2019; 8(6): 972 doi: 10.1039/c9tx00142e
|
| 56 |
Fabio Arnesano, Giovanni Natile. Interference between copper transport systems and platinum drugs. Seminars in Cancer Biology 2021; 76: 173 doi: 10.1016/j.semcancer.2021.05.023
|
| 57 |
Zixin Wu, Guishuai Lv, Fuxue Xing, Wei Xiang, Yue Ma, Qiyu Feng, Wen Yang, Hongyang Wang. Copper in hepatocellular carcinoma： A double-edged sword with therapeutic potentials. Cancer Letters 2023; 571: 216348 doi: 10.1016/j.canlet.2023.216348
|
| 58 |
Sumayah Mohammed Asiri, Aviva Levina, Elizabeth J. New, Peter A. Lay. Investigations of cellular copper metabolism in ovarian cancer cells using a ratiometric fluorescent copper dye. JBIC Journal of Biological Inorganic Chemistry 2022; 28(1): 43 doi: 10.1007/s00775-022-01978-9
|
| 59 |
Rui Fu, Borui Zhao, Min Chen, Xiaolong Fu, Qian Zhang, Yange Cui, Xin Hu, Wei Zhou. Moving beyond cisplatin resistance: mechanisms, challenges, and prospects for overcoming recurrence in clinical cancer therapy. Medical Oncology 2023; 41(1) doi: 10.1007/s12032-023-02237-w
|
| 60 |
Ze Yu, Weifan Cao, Yuan Ren, Qijia Zhang, Jia Liu. ATPase copper transporter A, negatively regulated by miR‐148a‐3p, contributes to cisplatin resistance in breast cancer cells. Clinical and Translational Medicine 2020; 10(1): 57 doi: 10.1002/ctm2.19
|
| 61 |
Lina Wang, Zejun Liu, Shumei He, Shasha He, Yupeng Wang. Fighting against drug-resistant tumors by the inhibition of γ-glutamyl transferase with supramolecular platinum prodrug nano-assemblies. Journal of Materials Chemistry B 2021; 9(22): 4587 doi: 10.1039/D1TB00149C
|
| 62 |
Shveta S. Motwani, Sharneet K. Sandhu, Abhijat Kitchlu. Cisplatin Nephrotoxicity: Novel Insights Into Mechanisms and Preventative Strategies. Seminars in Nephrology 2022; 42(6): 151341 doi: 10.1016/j.semnephrol.2023.151341
|
| 63 |
Szu-Jung Chen, Ching-Chuan Kuo, Hsin-Yi Pan, Tsui-Chun Tsou, Szu-Ching Yeh, Jang-Yang Chang. Desferal regulates hCtr1 and transferrin receptor expression through Sp1 and exhibits synergistic cytotoxicity with platinum drugs in oxaliplatin-resistant human cervical cancer cells in vitro and in vivo. Oncotarget 2016; 7(31): 49310 doi: 10.18632/oncotarget.10336
|
| 64 |
Peng Liu, Lu Hao, Min Liu, Shuo Hu. Glutathione-responsive and -exhausting metal nanomedicines for robust synergistic cancer therapy. Frontiers in Bioengineering and Biotechnology 2023; 11 doi: 10.3389/fbioe.2023.1161472
|
| 65 |
Andrei Havasi, Simona Sorana Cainap, Ana Teodora Havasi, Calin Cainap. Ovarian Cancer—Insights into Platinum Resistance and Overcoming It. Medicina 2023; 59(3): 544 doi: 10.3390/medicina59030544
|
| 66 |
Amy Buckley, Becky Bibby, Margaret Dunne, Susan Kennedy, Maria Davern, Breandán Kennedy, Stephen Maher, Jacintha O’Sullivan. Characterisation of an Isogenic Model of Cisplatin Resistance in Oesophageal Adenocarcinoma Cells. Pharmaceuticals 2019; 12(1): 33 doi: 10.3390/ph12010033
|
| 67 |
Mamoru Kakuda, Shinya Matsuzaki, Yutaka Ueda, Mayu Shiomi, Satoko Matsuzaki, Toshihiro Kimura, Masami Fujita, Tomomi Egawa-Takata, Eiji Kobayashi, Satoshi Serada, Kiyoshi Yoshino, Tetsuji Naka, Tadashi Kimura. Copper ions are novel therapeutic agents for uterine leiomyosarcoma. American Journal of Obstetrics and Gynecology 2020; 222(1): 64.e1 doi: 10.1016/j.ajog.2019.07.030
|
| 68 |
Alejandro Bravo-Cuellar, Pablo Cesar Ortiz-Lazareno, Erick Sierra-Díaz, Fabiola Solorzano-Ibarra, Anibal Samael Méndez-Clemente, Adriana Aguilar-Lemarroy, Luis Felipe Jave-Suárez, Édgar Ruiz Velazco-Niño, Georgina Hernández-Flores. Pentoxifylline Sensitizes Cisplatin-Resistant Human Cervical Cancer Cells to Cisplatin Treatment: Involvement of Mitochondrial and NF-Kappa B Pathways. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.592706
|
| 69 |
Mai A. Abd-Elmawla, Sherif S. Abdel Mageed, Tohada M. AL-Noshokaty, Mohammed S. Elballal, Ahmed I. Abulsoud, Shereen Saeid Elshaer, Ahmed A. El-Husseiny, Doaa Fathi, Heba M. Midan, Nehal I. Rizk, Mahmoud A. Elrebehy, Ghadir A. Sayed, Manar Mohammed El Tabaa, Aya Salman, Osama A. Mohammed, Alaa Ashraf, Emad Gamil Khidr, Reem Khaled, Walaa A. El-Dakroury, Gouda Kamel Helal, Yasser M. Moustafa, Ahmed S. Doghish. Melodic maestros: Unraveling the role of miRNAs in the diagnosis, progression, and drug resistance of malignant pleural mesothelioma. Pathology - Research and Practice 2023; 250: 154817 doi: 10.1016/j.prp.2023.154817
|
| 70 |
Veronica Cocetta, Eugenio Ragazzi, Monica Montopoli. . International Review of Cell and Molecular Biology 2020; 354: 107 doi: 10.1016/bs.ircmb.2020.01.005
|
| 71 |
Maria V. Babak, Dohyun Ahn. Modulation of Intracellular Copper Levels as the Mechanism of Action of Anticancer Copper Complexes: Clinical Relevance. Biomedicines 2021; 9(8): 852 doi: 10.3390/biomedicines9080852
|
| 72 |
Jaber Zafari, Nima Rastegar-Pouyani, Fatemeh Javani Jouni, Nabaa Najjar, Seyedeh Zohreh Azarshin, Emad Jafarzadeh, Parviz Abdolmaleki, Farshad Hoseini Shirazi. Static magnetic field reduces cisplatin resistance via increasing apoptosis pathways and genotoxicity in cancer cell lines. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-56605-1
|
| 73 |
Casey J. Adams, Thomas J. Meade. Towards Imaging Pt Chemoresistance Using Gd(III)‐Pt(II) Theranostic MR Contrast Agents. ChemMedChem 2021; 16(24): 3663 doi: 10.1002/cmdc.202100389
|
| 74 |
Tamara Mirzapoiazova, Gang Xiao, Bolot Mambetsariev, Mohd W. Nasser, Emily Miaou, Sharad S. Singhal, Saumya Srivastava, Isa Mambetsariev, Michael S. Nelson, Arin Nam, Amita Behal, Pranita Atri, Markus Muschen, François L.H. Tissot, James Miser, John S. Kovach, Martin Sattler, Surinder K. Batra, Prakash Kulkarni, Ravi Salgia. Protein Phosphatase 2A as a Therapeutic Target in Small Cell Lung Cancer. Molecular Cancer Therapeutics 2021; 20(10): 1820 doi: 10.1158/1535-7163.MCT-21-0013
|
| 75 |
Jamie R. Friedman, Stephen D. Richbart, Justin C. Merritt, Haley E. Perry, Kathleen C. Brown, Austin T. Akers, Nicholas A. Nolan, Cathryn D. Stevenson, John D. Hurley, Sarah L. Miles, Maria T. Tirona, Monica A. Valentovic, Piyali Dasgupta. . Advances in Cancer Research 2019; 144: 263 doi: 10.1016/bs.acr.2019.05.002
|
| 76 |
Laura Cabeza, Gloria Perazzoli, Cristina Mesas, Cristina Jiménez-Luna, José Prados, Ana Rosa Rama, Consolación Melguizo. Nanoparticles in Colorectal Cancer Therapy: Latest In Vivo Assays, Clinical Trials, and Patents. AAPS PharmSciTech 2020; 21(5) doi: 10.1208/s12249-020-01731-y
|
| 77 |
Ekaterina Ilyechova, Elisa Bonaldi, Iurii Orlov, Ekaterina Skomorokhova, Ludmila Puchkova, Massimo Broggini. CRISP-R/Cas9 Mediated Deletion of Copper Transport Genes CTR1 and DMT1 in NSCLC Cell Line H1299. Biological and Pharmacological Consequences. Cells 2019; 8(4): 322 doi: 10.3390/cells8040322
|
| 78 |
Yehuda G. Assaraf, Anamaria Brozovic, Ana Cristina Gonçalves, Dana Jurkovicova, Aija Linē, Miguel Machuqueiro, Simona Saponara, Ana Bela Sarmento-Ribeiro, Cristina P.R. Xavier, M. Helena Vasconcelos. The multi-factorial nature of clinical multidrug resistance in cancer. Drug Resistance Updates 2019; 46: 100645 doi: 10.1016/j.drup.2019.100645
|
| 79 |
Valeria A. Ferretti, Ignacio E. León. Long Non-coding RNAs in Cisplatin Resistance in Osteosarcoma. Current Treatment Options in Oncology 2021; 22(5) doi: 10.1007/s11864-021-00839-y
|
| 80 |
Larissa Kotelevets, Eric Chastre, Didier Desmaële, Patrick Couvreur. Nanotechnologies for the treatment of colon cancer: From old drugs to new hope. International Journal of Pharmaceutics 2016; 514(1): 24 doi: 10.1016/j.ijpharm.2016.06.005
|
| 81 |
Beatriz García-Pinel, Cristina Porras-Alcalá, Laura Cabeza, Raul Ortiz, José Prados, Consolación Melguizo, Iván Cheng-Sánchez, Juan Manuel López-Romero, Francisco Sarabia. Bengamide Analogues Show A Potent Antitumor Activity against Colon Cancer Cells: A Preliminary Study. Marine Drugs 2020; 18(5): 240 doi: 10.3390/md18050240
|
| 82 |
Silvia Baldari, Giuliana Di Rocco, Gabriele Toietta. Current Biomedical Use of Copper Chelation Therapy. International Journal of Molecular Sciences 2020; 21(3): 1069 doi: 10.3390/ijms21031069
|
| 83 |
Zhijian Luo, Yantao Luo, Xiaoling Liang, Qingyang Lyu, Fanliang Meng, Xuncai Chen, Yupeng Wang, Weiyi Fang, Aimin Li, Dongfang Zhou. Alantolactone-Loaded Pegylated Prodrug Nanocarriers for Synergistic Treatment of Cisplatin-Resistant Ovarian Cancer via Reactivating Mitochondrial Apoptotic Pathway. ACS Biomaterials Science & Engineering 2022; 8(6): 2526 doi: 10.1021/acsbiomaterials.2c00316
|
| 84 |
Michelle McMullen, Ainhoa Madariaga, Stephanie Lheureux. New approaches for targeting platinum-resistant ovarian cancer. Seminars in Cancer Biology 2021; 77: 167 doi: 10.1016/j.semcancer.2020.08.013
|
| 85 |
Mohammad Aslam Khan, Kunwar Somesh Vikramdeo, Sarabjeet Kour Sudan, Seema Singh, Annelise Wilhite, Santanu Dasgupta, Rodney Paul Rocconi, Ajay Pratap Singh. Platinum-resistant ovarian cancer: From drug resistance mechanisms to liquid biopsy-based biomarkers for disease management. Seminars in Cancer Biology 2021; 77: 99 doi: 10.1016/j.semcancer.2021.08.005
|
| 86 |
Michelle McMullen, Katherine Karakasis, Ainhoa Madariaga, Amit M. Oza. Overcoming Platinum and PARP-Inhibitor Resistance in Ovarian Cancer. Cancers 2020; 12(6): 1607 doi: 10.3390/cancers12061607
|
| 87 |
Lude Wang, Xiaoya Zhao, Jianfei Fu, Wenxia Xu, Jianlie Yuan. The Role of Tumour Metabolism in Cisplatin Resistance. Frontiers in Molecular Biosciences 2021; 8 doi: 10.3389/fmolb.2021.691795
|
| 88 |
Luna Acharya, Hariharasudan Mani, Aman Ullah, Sana Hussain, Saeed Ali, Sarfraz Ahmad. Overcoming Drug Resistance in Gynecologic Cancers. 2021; : 49 doi: 10.1016/B978-0-12-824299-5.00007-1
|